Mitochondrial DNA is a direct target of anti-cancer anthracycline drugs

Biochemical and Biophysical Research Communications

Volumn 378, Issue 3, 2009, Pages 450-455

  Ashley, Neil ^a   Poulton, Joanna ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Anthracyclines; Cardiolipin; Doxorubicin; Ethidium bromide; Mitochondria; mtDNA; PicoGreen

Indexed keywords

CARDIOLIPIN; CELL NUCLEUS DNA; DOXORUBICIN; ETHIDIUM BROMIDE; FLUORESCENT DYE; MITOCHONDRIAL DNA;

ARTICLE; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VIVO STUDY; MITOCHONDRIAL TOXICITY; PRIORITY JOURNAL;

ANTHRACYCLINES; ANTINEOPLASTIC AGENTS; CELL LINE; DNA, MITOCHONDRIAL; DOXORUBICIN; FLUORESCENT DYES; HUMANS; INTERCALATING AGENTS; ORGANIC CHEMICALS;

EID: 57749191024     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2008.11.059     Document Type: Article

References (30)

1. Gewirtz D.A. A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin. Biochem. Pharmacol. 57 (1999) 727-741
2. Minotti G., Menna P., Salvatorelli E., Cairo G., and Gianni L. Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity. Pharmacol. Rev. 56 (2004) 185-229
3. Singal P.K., and Iliskovic N. Doxorubicin-induced cardiomyopathy. N. Engl. J. Med. 339 (1998) 900-905
4. Barrett C.M., Lewis F.L., Roaten J.B., Sweatman T.W., Israel M., Cleveland J.L., and Lothstein L. Novel extranuclear-targeted anthracyclines override the antiapoptotic functions of Bcl-2 and target protein kinase C pathways to induce apoptosis. Mol. Cancer Ther. 1 (2002) 469-481
5. Jung K., and Reszka R. Mitochondria as subcellular targets for clinically useful anthracyclines. Adv. Drug Deliv. Rev. 49 (2001) 87-105
6. Conklin K.A. Coenzyme q10 for prevention of anthracycline-induced cardiotoxicity. Integr. Cancer Ther. 4 (2005) 110-130
7. Wallace K.B. Doxorubicin-induced cardiac mitochondrionopathy. Pharmacol. Toxicol. 93 (2003) 105-115
8. Ainger L.E., Bushore J., Johnson W.W., and Ito J. Daunomycin: a cardiotoxic agent. J. Natl. Med. Assoc. 63 (1971) 261-267
9. Rosenoff S.H., Olson H.M., Young D.M., Bostick F., and Young R.C. Adriamycin-induced cardiac damage in the mouse: a small-animal model of cardiotoxicity. J. Natl. Cancer Inst. 55 (1975) 191-194
10. Goormaghtigh E., Huart P., Praet M., Brasseur R., and Ruysschaert J.M. Structure of the adriamycin-cardiolipin complex. Role in mitochondrial toxicity. Biophys. Chem. 35 (1990) 247-257
11. Cheneval D., Muller M., Toni R., Ruetz S., and Carafoli E. Adriamycin as a probe for the transversal distribution of cardiolipin in the inner mitochondrial membrane. J. Biol. Chem. 260 (1985) 13003-13007
12. Nicolay K., Timmers R.J., Spoelstra E., Van der Neut R., Fok J.J., Huigen Y.M., Verkleij A.J., and De Kruijff B. The interaction of adriamycin with cardiolipin in model and rat liver mitochondrial membranes. Biochim. Biophys. Acta 778 (1984) 359-371
13. Cullinane C., Cutts S.M., Panousis C., and Phillips D.R. Interstrand cross-linking by adriamycin in nuclear and mitochondrial DNA of MCF-7 cells. Nucleic Acids Res. 28 (2000) 1019-1025
14. Palmeira C.M., Serrano J., Kuehl D.W., and Wallace K.B. Preferential oxidation of cardiac mitochondrial DNA following acute intoxication with doxorubicin. Biochim. Biophys. Acta 1321 (1997) 101-106
15. Lebrecht D., Setzer B., Ketelsen U.P., Haberstroh J., and Walker U.A. Time-dependent and tissue-specific accumulation of mtDNA and respiratory chain defects in chronic doxorubicin cardiomyopathy. Circulation 108 (2003) 2423-2429
16. Lebrecht D., Kokkori A., Ketelsen U.P., Setzer B., and Walker U.A. Tissue-specific mtDNA lesions and radical-associated mitochondrial dysfunction in human hearts exposed to doxorubicin. J. Pathol. 207 (2005) 436-444
17. Salvatorelli E., Guarnieri S., Menna P., Liberi G., Calafiore A.M., Mariggio M.A., Mordente A., Gianni L., and Minotti G. Defective one- or two-electron reduction of the anticancer anthracycline epirubicin in human heart. Relative importance of vesicular sequestration and impaired efficiency of electron addition. J. Biol. Chem. 281 (2006) 10990-11001
18. Nicolay K., Fok J.J., Voorhout W., Post J.A., and de Kruijff B. Cytofluorescence detection of adriamycin-mitochondria interactions in isolated. Perfused rat heart. Biochim. Biophys. Acta 887 (1986) 35-41
19. Beyer U., Rothern-Rutishauser B., Unger C., Wunderli-Allenspach H., and Kratz F. Differences in the intracellular distribution of acid-sensitive doxorubicin-protein conjugates in comparison to free and liposomal formulated doxorubicin as shown by confocal microscopy. Pharm. Res. 18 (2001) 29-38
20. Krishan A., Ganapathi R.N., and Israel M. Effect of adriamycin and analogs on the nuclear fluorescence of propidium iodide-stained cells. Cancer Res. 38 (1978) 3656-3662
21. Belloc F., Lacombe F., Dumain P., Lopez F., Bernard P., Boisseau M.R., and Reifers J. Intercalation of anthracyclines into living cell DNA analyzed by flow cytometry. Cytometry 13 (1992) 880-885
22. Ashley N., Adams S., Slama A., Zeviani M., Suomalainen A., Andreu A.L., Naviaux R.K., and Poulton J. Defects in maintenance of mitochondrial DNA are associated with intramitochondrial nucleotide imbalances. Hum. Mol. Genet. 16 (2007) 1400-1411
23. Ashley N., Harris D., and Poulton J. Detection of mitochondrial DNA depletion in living human cells using PicoGreen staining. Exp. Cell Res. 303 (2005) 432-446
24. Ashley N., O'Rourke A., Smith C., Adams S., Gowda V., Zeviani M., Brown G.K., Fratter C., and Poulton J. Depletion of mitochondrial DNA in fibroblast cultures from patients with POLG1 mutations is a consequence of catalytic mutations. Hum. Mol. Genet. 17 (2008) 2496-2506
25. Morten K.J., Ashley N., Wijburg F., Hadzic N., Parr J., Jayawant S., Adams S., Bindoff L., Bakker H.D., Mieli-Vergani G., Zeviani M., and Poulton J. Liver mtDNA content increases during development: a comparison of methods and the importance of age- and tissue-specific controls for the diagnosis of mtDNA depletion. Mitochondrion 7 (2007) 386-395
26. Valianpour F., Wanders R.J., Overmars H., Vreken P., Van Gennip A.H., Baas F., Plecko B., Santer R., Becker K., and Barth P.G. Cardiolipin deficiency in X-linked cardioskeletal myopathy and neutropenia (Barth syndrome, MIM 302060): a study in cultured skin fibroblasts. J. Pediatr. 141 (2002) 729-733
27. Bogush T., and Robert J. Comparative evaluation of the intracellular accumulation and DNA binding of idarubicin and daunorubicin in sensitive and multidrug-resistant human leukaemia K562 cells. Anticancer Res. 16 (1996) 365-368
28. Houtkooper R.H., and Vaz F.M. Cardiolipin, the heart of mitochondrial metabolism. Cell. Mol. Life Sci. 65 (2008) 2493-2506
29. King M.P., and Attardi G. Human cells lacking mtDNA: repopulation with exogenous mitochondria by complementation. Science 246 (1989) 500-503
30. Tyynismaa H., Sembongi H., Bokori-Brown M., Granycome C., Ashley N., Poulton J., Jalanko A., Spelbrink J.N., Holt I.J., and Suomalainen A. Twinkle helicase is essential for mtDNA maintenance and regulates mtDNA copy number. Hum. Mol. Genet. 13 (2004) 3219-3227